Lab Notes

A landmark study shows evolocumab slashes first-time heart events by 25% in high-risk patients. New research reveals how protein type and dose affect amino acid delivery, while free amino acids offer faster absorption than whole protein—without boosting muscle synthesis. Meanwhile, viral videos on cancer-feeding foods and lifter-focused supplements show mixed scientific backing.

This week's analysis reveals fascinating insights into pain management with TENS devices, highlighting strong placebo effects in neuromyelitis optica patients. Additionally, a new targeted epigenetic clock offers a cost-effective way to measure biological age, while a viral video claims artery-repairing benefits from an alternative to walking.